(5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one

Invented is the compound (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3,-thiazol-4(5H)-one, and/or pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are pharmaceutical compositions containing this compound, methods of prepairing this com...

Full description

Saved in:
Bibliographic Details
Main Authors FITCH, DUKE M, DUFFY, KEVIN J, NORTON, BETH A
Format Patent
LanguageChinese
English
Published 01.05.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Invented is the compound (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3,-thiazol-4(5H)-one, and/or pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are pharmaceutical compositions containing this compound, methods of prepairing this compound and pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are methods of using this compound as an inhibitor of hYAK3 proteins.
AbstractList Invented is the compound (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3,-thiazol-4(5H)-one, and/or pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are pharmaceutical compositions containing this compound, methods of prepairing this compound and pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are methods of using this compound as an inhibitor of hYAK3 proteins.
Author FITCH, DUKE M
DUFFY, KEVIN J
NORTON, BETH A
Author_xml – fullname: FITCH, DUKE M
– fullname: DUFFY, KEVIN J
– fullname: NORTON, BETH A
BookMark eNrjYmDJy89L5WQI0zCN0tQ11dUw0y0szczLr0jMycyrzMlNLcmozMlMSc1L1dQ10o3WMNIx003JTM7IyS_KL8hIBSrRTMwFqo_VNdQx1i3JyEysys_RNdEw9dDUBRrMw8CalphTnMoLpbkZFN1cQ5w9dFML8uNTiwsSk4Eml8SHhBsZGJgbmplaGDgaE6MGAIKAN-I
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID TW200716580A
GroupedDBID EVB
ID FETCH-epo_espacenet_TW200716580A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:57:32 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_TW200716580A3
Notes Application Number: TW200695119940
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070501&DB=EPODOC&CC=TW&NR=200716580A
ParticipantIDs epo_espacenet_TW200716580A
PublicationCentury 2000
PublicationDate 20070501
PublicationDateYYYYMMDD 2007-05-01
PublicationDate_xml – month: 05
  year: 2007
  text: 20070501
  day: 01
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies SMITHKLINE BEECHAM CORPORATION
RelatedCompanies_xml – name: SMITHKLINE BEECHAM CORPORATION
Score 2.7750256
Snippet Invented is the compound (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3,-thiazol-4(5H)-one, and/or pharmaceutically acceptable salts,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070501&DB=EPODOC&locale=&CC=TW&NR=200716580A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvVNUaP4EU0M2RIuAtsKeyBGNggx4SNmAtEQso8uYHBDGVH4671OEF_0rWmvTXvJ9ddre78DuBZkOYypJeQuV1D1fB1113OF4fmCzKXISyLeudFk9Uf1vqf1EvCyioWJeUI_YnJEsiiX7D2K9-vJ-hLLjP9WTm-cEVWFtzWrbGZW3nExp5FvbFbK1XbLbBkZwyhb3UzzIW7LE9rm7jZgUxyjBc9-tVMRUSmT35BS24OtNo0WRPuQWAxTsGOsMq-lYLuxfPCm4tL2pgfQkbQnGTWUGL7NRkH4SSfoYD4WKaDnY5EalMtYwGepkGVI3YfkiAvOABKR7VeS72M-q2A0HNmLcIyqpNVlDAN-CFe1qmXUkSY4-NHGwOqu16IcQTIg0WO49Bh38wXH9wi_ScW-nvMJoGy7qDBH575zAum_x0n_13gKu98XmuKX3xkko_cZPyckjpyLWIVfoEuLbg
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3rT8IwEL8gGvGbzyi-E0O2hEZgW8c-ECMbZCqvmAlEY8geXcDghjKi8Nd7nSB-0W9Ne23aS66_Xtv7HcAFJ8uhVC4S5jKJyJ6vEc31XG54PidzUVmRxzvXG9R8kG-7SjcBL4tYmJgn9CMmR0SLctHeo3i_Hi0vsYz4b-X40hlgVXhVtUpGZuEdqzkFfWOjXKq0mkZTz-h6yepkGvdxWx7RNne9AqsquoScZ7_SLvOolNFvSKluwloLRwuiLUjM-tuQ0heZ17ZhvT5_8Mbi3PbGO9AWlEeRKESg5G0yCMJPPEEH0yFPAT0d8tSgTCQF8iQUspRg9z464pwzAEVE-xXln0k-K5GoP7Bn4ZDIgmKKJAzYLpxXK5ZuEpxg70cbPauzXIu0B8kARffhzKPMzRcc30P8RhX7Ws5HgLJtVaKOxnznANJ_j5P-r_EUUqZVr_VqN427Q9j4vtzkP_6OIBm9T9gxonLknMTq_AJMGo5Z
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%285Z%29-5-%286-quinoxalinylmethylidene%29-2-%5B%282%2C6-dichlorophenyl%29amino%5D-1%2C3-thiazol-4%285H%29-one&rft.inventor=FITCH%2C+DUKE+M&rft.inventor=DUFFY%2C+KEVIN+J&rft.inventor=NORTON%2C+BETH+A&rft.date=2007-05-01&rft.externalDBID=A&rft.externalDocID=TW200716580A